SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma

Background: Adrenocortical carcinoma (ACC) is an aggressive malignancy with limited medical treatment options. We previously identified polo-like kinase 1 (PLK1) as one of most overexpressed genes in ACC; thus PLK1 represents a potential treatment target for this cancer type. Some PLK1 inhibitors ar...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Endocr Soc
Prif Awduron: Smith, Gabrielle, Liang, Raimunde, Chortis, Vasileios, Khan, Sana, Lippert, Juliane, Hantel, Constanze, Altieri, Barbara, Fassnacht, Martin, Foster, Paul Alexander, Ronchi, Cristina Lucia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2020
Pynciau:
Tumor Biology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208647/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2164
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg